abstract |
Bispecific heterodimeric diabody molecules and their use in the treatment of cancer. The bispecific heterodimeric diabody molecule comprises two polypeptide chains that bind to form two epitope binding sites that recognize the P-cadherin tumor cell associated antigen and the CD3 T cell antigen. [Figure 1] |